News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Conference News TCT 2023 BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years Caitlin E. Cox October 27, 2023
News Conference News TCT 2023 OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions Todd Neale October 23, 2023
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
News Conference News TCT 2020 Stent Polymer Face-off Calls Bioresorbable Coatings Into Question Shelley Wood October 17, 2020
News Conference News TCT 2020 Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate Shelley Wood October 14, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Conference News TCT 2016 No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low Shelley Wood November 07, 2016
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015